高盛：诺诚健华_2025 年中国医疗保健企业日 —— 关键要点

25 June 2025 | 10:06PM HKT InnoCare Pharma (9969.HK): China Healthcare Corporate Day 2025 — Key Takeaways: Target one major BD deal in 2H25 Presenters: Bonnie Yuan - Investor Relations Director Honglin Yan +852-2978-6666 | honglin.yan@gs.com Goldman Sachs (Asia) L.L.C. c45a43530f604d12bcb9a82b5aa6b9f6 Goldman Sachs InnoCare Pharma (9969.HK) Bottom line: management noted on-track commercial progress in 2Q and guided one major BD deal in 2H25. We expect potential licensing-out opportunities to come from two T ...